Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice

Lindsay J. Ledwich, Kofi Clarke

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

BACKGROUND:: Despite increased awareness of glucocorticoid-induced osteoporosis, physicians are not providing recommended screening and treatment. The number of patients receiving bone density measurements, primary prevention, and secondary treatment remains low. OBJECTIVES:: To analyze physician adherence of rheumatologists in an urban multispecialty group to the American College of Rheumatology 2001 ad hoc committee guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis (RA). METHODS:: The practice evaluated is a multispecialty practice in an urban setting affiliated with a teaching hospital. A retrospective chart review was performed. The names of 428 patients with RA were obtained by billing query. One hundred thirty-six charts met criteria for final analysis. Charts were reviewed for long-term corticosteroid use ≥5 mg/d for ≥6 months, baseline bone density scans, use of calcium and vitamin D, use of hormone replacement therapy, use of calcitonin, and use of a bisphosphonate. RESULTS:: 59.7% of patients qualified as long-term corticosteroid users. Only 37% of long-term corticosteroid users received baseline bone density scans. Bone loss was documented in 70.4% of corticosteroid users who received baseline DEXA scans. Only 38.9% of long-term corticosteroid users received the recommended treatment of bisphosphonates or HRT with calcium plus vitamin D according to ACR guidelines. CONCLUSIONS:: Less then 40% of long-term corticosteroid users with RA received recommended DEXA scanning and treatment in a multispecialty rheumatology urban practice.

Original languageEnglish (US)
Pages (from-to)61-64
Number of pages4
JournalJournal of Clinical Rheumatology
Volume15
Issue number2
DOIs
StatePublished - Mar 1 2009

Fingerprint

Glucocorticoids
Osteoporosis
Rheumatoid Arthritis
Adrenal Cortex Hormones
Bone Density
Diphosphonates
Vitamin D
Therapeutics
Guidelines
Calcium
Physicians
Hormone Replacement Therapy
Photon Absorptiometry
Calcitonin
Rheumatology
Primary Prevention
Teaching Hospitals
Names
Bone and Bones

All Science Journal Classification (ASJC) codes

  • Rheumatology
  • Medicine(all)

Cite this

@article{de8ad3191e70416dac6c9ca6ffd8f95c,
title = "Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice",
abstract = "BACKGROUND:: Despite increased awareness of glucocorticoid-induced osteoporosis, physicians are not providing recommended screening and treatment. The number of patients receiving bone density measurements, primary prevention, and secondary treatment remains low. OBJECTIVES:: To analyze physician adherence of rheumatologists in an urban multispecialty group to the American College of Rheumatology 2001 ad hoc committee guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis (RA). METHODS:: The practice evaluated is a multispecialty practice in an urban setting affiliated with a teaching hospital. A retrospective chart review was performed. The names of 428 patients with RA were obtained by billing query. One hundred thirty-six charts met criteria for final analysis. Charts were reviewed for long-term corticosteroid use ≥5 mg/d for ≥6 months, baseline bone density scans, use of calcium and vitamin D, use of hormone replacement therapy, use of calcitonin, and use of a bisphosphonate. RESULTS:: 59.7{\%} of patients qualified as long-term corticosteroid users. Only 37{\%} of long-term corticosteroid users received baseline bone density scans. Bone loss was documented in 70.4{\%} of corticosteroid users who received baseline DEXA scans. Only 38.9{\%} of long-term corticosteroid users received the recommended treatment of bisphosphonates or HRT with calcium plus vitamin D according to ACR guidelines. CONCLUSIONS:: Less then 40{\%} of long-term corticosteroid users with RA received recommended DEXA scanning and treatment in a multispecialty rheumatology urban practice.",
author = "Ledwich, {Lindsay J.} and Kofi Clarke",
year = "2009",
month = "3",
day = "1",
doi = "10.1097/RHU.0b013e31819b65bd",
language = "English (US)",
volume = "15",
pages = "61--64",
journal = "Journal of Clinical Rheumatology",
issn = "1076-1608",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice. / Ledwich, Lindsay J.; Clarke, Kofi.

In: Journal of Clinical Rheumatology, Vol. 15, No. 2, 01.03.2009, p. 61-64.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice

AU - Ledwich, Lindsay J.

AU - Clarke, Kofi

PY - 2009/3/1

Y1 - 2009/3/1

N2 - BACKGROUND:: Despite increased awareness of glucocorticoid-induced osteoporosis, physicians are not providing recommended screening and treatment. The number of patients receiving bone density measurements, primary prevention, and secondary treatment remains low. OBJECTIVES:: To analyze physician adherence of rheumatologists in an urban multispecialty group to the American College of Rheumatology 2001 ad hoc committee guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis (RA). METHODS:: The practice evaluated is a multispecialty practice in an urban setting affiliated with a teaching hospital. A retrospective chart review was performed. The names of 428 patients with RA were obtained by billing query. One hundred thirty-six charts met criteria for final analysis. Charts were reviewed for long-term corticosteroid use ≥5 mg/d for ≥6 months, baseline bone density scans, use of calcium and vitamin D, use of hormone replacement therapy, use of calcitonin, and use of a bisphosphonate. RESULTS:: 59.7% of patients qualified as long-term corticosteroid users. Only 37% of long-term corticosteroid users received baseline bone density scans. Bone loss was documented in 70.4% of corticosteroid users who received baseline DEXA scans. Only 38.9% of long-term corticosteroid users received the recommended treatment of bisphosphonates or HRT with calcium plus vitamin D according to ACR guidelines. CONCLUSIONS:: Less then 40% of long-term corticosteroid users with RA received recommended DEXA scanning and treatment in a multispecialty rheumatology urban practice.

AB - BACKGROUND:: Despite increased awareness of glucocorticoid-induced osteoporosis, physicians are not providing recommended screening and treatment. The number of patients receiving bone density measurements, primary prevention, and secondary treatment remains low. OBJECTIVES:: To analyze physician adherence of rheumatologists in an urban multispecialty group to the American College of Rheumatology 2001 ad hoc committee guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis (RA). METHODS:: The practice evaluated is a multispecialty practice in an urban setting affiliated with a teaching hospital. A retrospective chart review was performed. The names of 428 patients with RA were obtained by billing query. One hundred thirty-six charts met criteria for final analysis. Charts were reviewed for long-term corticosteroid use ≥5 mg/d for ≥6 months, baseline bone density scans, use of calcium and vitamin D, use of hormone replacement therapy, use of calcitonin, and use of a bisphosphonate. RESULTS:: 59.7% of patients qualified as long-term corticosteroid users. Only 37% of long-term corticosteroid users received baseline bone density scans. Bone loss was documented in 70.4% of corticosteroid users who received baseline DEXA scans. Only 38.9% of long-term corticosteroid users received the recommended treatment of bisphosphonates or HRT with calcium plus vitamin D according to ACR guidelines. CONCLUSIONS:: Less then 40% of long-term corticosteroid users with RA received recommended DEXA scanning and treatment in a multispecialty rheumatology urban practice.

UR - http://www.scopus.com/inward/record.url?scp=67449085324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67449085324&partnerID=8YFLogxK

U2 - 10.1097/RHU.0b013e31819b65bd

DO - 10.1097/RHU.0b013e31819b65bd

M3 - Article

VL - 15

SP - 61

EP - 64

JO - Journal of Clinical Rheumatology

JF - Journal of Clinical Rheumatology

SN - 1076-1608

IS - 2

ER -